- Home
- FBNC vs MNKD Comparison
FBNC vs MNKD Comparison
Compare FBNC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBNC
- MNKD
- Stock Information
- Founded
- FBNC 1934
- MNKD 1991
- Country
- FBNC United States
- MNKD United States
- Employees
- FBNC N/A
- MNKD N/A
- Industry
- FBNC Major Banks
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- FBNC Finance
- MNKD Health Care
- Exchange
- FBNC Nasdaq
- MNKD Nasdaq
- Market Cap
- FBNC 1.7B
- MNKD 1.6B
- IPO Year
- FBNC N/A
- MNKD 2004
- Fundamental
- Price
- FBNC $39.98
- MNKD $4.99
- Analyst Decision
- FBNC Buy
- MNKD Buy
- Analyst Count
- FBNC 3
- MNKD 6
- Target Price
- FBNC $52.00
- MNKD $8.92
- AVG Volume (30 Days)
- FBNC 190.8K
- MNKD 2.0M
- Earning Date
- FBNC 04-23-2025
- MNKD 05-07-2025
- Dividend Yield
- FBNC 2.18%
- MNKD N/A
- EPS Growth
- FBNC N/A
- MNKD N/A
- EPS
- FBNC 1.84
- MNKD 0.10
- Revenue
- FBNC $333,724,000.00
- MNKD $285,504,000.00
- Revenue This Year
- FBNC $32.94
- MNKD $14.66
- Revenue Next Year
- FBNC $5.80
- MNKD $14.27
- P/E Ratio
- FBNC $21.87
- MNKD $50.30
- Revenue Growth
- FBNC N/A
- MNKD 43.50
- 52 Week Low
- FBNC $29.53
- MNKD $3.97
- 52 Week High
- FBNC $50.34
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- FBNC 43.99
- MNKD 37.28
- Support Level
- FBNC $39.73
- MNKD $5.16
- Resistance Level
- FBNC $42.65
- MNKD $5.28
- Average True Range (ATR)
- FBNC 1.17
- MNKD 0.15
- MACD
- FBNC 0.23
- MNKD 0.01
- Stochastic Oscillator
- FBNC 45.02
- MNKD 22.64
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.